Goldman Sachs Group Inc Abb Vie Inc. Put Options Transaction History

Goldman Sachs Group Inc

$605 Billion
Q3 2024

Put Options

19 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$163.84 - $199.33 $2.79 Million - $3.39 Million	17,000 Added 4.89%	364,300 $71.9 Million
Q2 2024 Aug 13, 2024	SELL	$154.79 - $180.76 $603,681 - $704,964	-3,900 Reduced 1.11%	347,300 $59.6 Million
Q1 2024 May 15, 2024	SELL	$159.82 - $182.1 $2.81 Million - $3.2 Million	-17,600 Reduced 4.77%	351,200 $64 Million
Q4 2023 Feb 13, 2024	SELL	$137.6 - $154.97 $24.6 Million - $27.7 Million	-178,800 Reduced 32.65%	368,800 $57.2 Million
Q3 2023 May 14, 2024	BUY	$133.59 - $154.65 $23.9 Million - $27.7 Million	178,800 Added 48.48%	547,600 $81.6 Million
Q3 2023 Nov 14, 2023	BUY	$133.59 - $154.65 $7.95 Million - $9.2 Million	59,500 Added 12.19%	547,600 $81.6 Million
Q2 2023 May 14, 2024	BUY	$132.51 - $164.9 $30.6 Million - $38.1 Million	231,100 Added 89.92%	488,100 $65.8 Million
Q2 2023 Aug 14, 2023	BUY	$132.51 - $164.9 $30.6 Million - $38.1 Million	231,100 Added 89.92%	488,100 $65.8 Million
Q1 2023 May 14, 2024	SELL	$144.61 - $166.54 $4.71 Million - $5.43 Million	-32,600 Reduced 11.26%	257,000 $41 Million
Q1 2023 May 11, 2023	SELL	$144.61 - $166.54 $4.71 Million - $5.43 Million	-32,600 Reduced 11.26%	257,000 $41 Million
Q4 2022 May 14, 2024	BUY	$138.31 - $165.87 $11.5 Million - $13.8 Million	83,000 Added 40.17%	289,600 $46.8 Million
Q4 2022 Feb 13, 2023	BUY	$138.31 - $165.87 $11.5 Million - $13.8 Million	83,000 Added 40.17%	289,600 $46.8 Million
Q3 2022 May 14, 2024	SELL	$134.21 - $153.93 $7.33 Million - $8.4 Million	-54,600 Reduced 20.9%	206,600 $27.7 Million
Q3 2022 Nov 10, 2022	SELL	$134.21 - $153.93 $7.33 Million - $8.4 Million	-54,600 Reduced 20.9%	206,600 $27.7 Million
Q2 2022 May 14, 2024	SELL	$137.62 - $174.96 $14.8 Million - $18.8 Million	-107,600 Reduced 29.18%	261,200 $40 Million
Q2 2022 Aug 15, 2022	BUY	$137.62 - $174.96 $4.36 Million - $5.55 Million	31,700 Added 13.81%	261,200 $40 Million
Q1 2022 May 16, 2022	SELL	$131.98 - $163.75 $45.7 Million - $56.7 Million	-346,300 Reduced 60.14%	229,500 $37.2 Million
Q4 2021 Feb 14, 2022	BUY	$107.43 - $135.93 $5.75 Million - $7.27 Million	53,500 Added 10.24%	575,800 $78 Million
Q3 2021 Nov 10, 2021	BUY	$106.4 - $120.78 $55.6 Million - $63.1 Million	522,300 New	522,300 $56.3 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Account